Tim Kendall
Angel Investor · at Common Metal
San Francisco, United States
Tim Kendall is a seed investor at Common Metal in San Francisco focused on Health Care and Artificial Intelligence. Tim Kendall is the Co-Founder of Moment.He attend to the Stanford University Graduate School of Business in 2004.
- Total investments:
- 33
- Last investment:
- Lead investor:
- 6%
Last updated:
For AI agents: llms.txt
Industries Tim Kendall invests in
Stages Tim Kendall invests in
Countries Tim Kendall invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $175k–$8M
- Angel
- $750k–$1.5M
- Series A
- $10M–$65M
Investment Focus
Industry
- Health Care 9 (27%)
- Artificial Intelligence 5 (15%)
- Wellness 4 (12%)
- E-Commerce 4 (12%)
- Personal Health 4 (12%)
Stage
- Seed 16 (48%)
- Series A 4 (12%)
- Angel 2 (6%)
- Series C 2 (6%)
- Series B 1 (3%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Everyday Agents is pioneering the development of LLM-powered Agents for high-consideration conversations | Seed / Jun 01, 2023 | ||
| Checkmate's a browser extension that generates you personalized deals based on who you are at 100k online stores. Your data's everywhere. Put it to work. Tell Checkmate about yourself in 30 seconds and start saving everywhere. | $15M / Series A / May 25, 2023 | ||
| Alto Neuroscience is a clinical-stage biopharmaceutical company that integrates the biology of the patient into drug development to improve the lives of people with mental health conditions. Through its AI-enabled biomarker platform, Alto Neuroscience combines rich sources of information on patients’ brain activity and behavior to rapidly develophighly-effective medicines for targeted populations. Alto Neuroscience aims to replace today's trial-and-error clinical approach by aligning the right Alto drug with the right patient, redefining psychiatry at a time when the world needs it most. | $32M / Series A / May 03, 2021 | ||
| Pendulum is empowering people with groundbreaking products and tools to achieve long-term health. | Seed / Jan 20, 2021 | ||
| Pace provides online peer support groups to give and receive support, therapy for diagnosed conditions like addiction or depression. | Seed / Jan 13, 2021 | ||
| Pace provides online peer support groups to give and receive support, therapy for diagnosed conditions like addiction or depression. | $1.9M / Seed / Jan 13, 2021 | ||
| Momentum is an OS/inbox and copilot for anyone who runs a pipeline (sales, fundraising, success, hiring, etc). Powered by behavioral science, useful AI, and thoughtful people. | Seed / Jan 01, 2021 | ||
| healthcare platform | Seed / Dec 18, 2020 | ||
|
Pumpkin Pie
|
app | Seed / Nov 18, 2020 | |
Actuate Health
|
Actuate Health develops and markets technologies in the biosensor and digital health industry.The company's focus is on developing technologies that can provide diagnostic, therapeutic, and preventative tools to fight the current Covid-19 pandemic and future respiratory viruses. Actuate’s technology is also being applied to the wellness andfitness market, providing systems to train pulmonary function for improved athletic performance and general wellness.It was founded in Castle Rock, Colorado in 2020. | Seed / Nov 04, 2020 | |
| See all 33 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Featured in Investor Lists
Recommended lists
FAQ
What does Tim Kendall invest in?
Tim Kendall invests primarily in Health Care, Artificial Intelligence and Wellness startups, most often at Seed and Series A stage. Most of the 33 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Tim Kendall invest in?
Tim Kendall typically joins rounds of $175k–$8M at Seed, $750k–$1.5M at Angel and $10M–$65M at Series A. These are whole funding-round sizes, not Tim Kendall's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Tim Kendall took part in.
How do I contact Tim Kendall?
Public channels for Tim Kendall include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Tim Kendall last invest?
The most recent investment recorded for Tim Kendall closed in Jun 2023. Shizune tracks 33 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
